Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03269279
Study type Interventional
Source Gynuity Health Projects
Contact Meighan Tarnagada, MPH
Phone 212.448.1230
Email mtarnagada@gynuity.org
Status Recruiting
Phase Phase 3
Start date May 20, 2017
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT02694198 - Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion N/A
Completed NCT01860521 - Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Termination of Pregnancy Analgesia N/A
Withdrawn NCT04304365 - Home Follow-up After Medication Abortion N/A
Completed NCT03400358 - Uterocervical Angle in the Pregnancy Termination of Multiparous Women N/A
Recruiting NCT05342467 - Gemeprost Versus Dinoprostone in First Trimester Miscarriages Phase 2
Completed NCT02381223 - Simplified Medical Abortion Screening: A Pilot Demonstration Project N/A
Recruiting NCT05940233 - Comparison of Rate of Complete Abortion Between Letrozole Plus Misoprostol vs Misoprostol Alone N/A
Not yet recruiting NCT03570307 - Fertility and Obstetric Outcomes After Medical Management Versus Surgical Treatment for First-trimester Miscarriage First-trimester Miscarriage N/A
Completed NCT01943279 - Comparison of Telephone Follow-up With In-person Follow-up After Medical Abortion N/A
Not yet recruiting NCT04194658 - Effectiveness of Pretreatment Letrozole Versus Misoprostol Alone in Missed Abortion Phase 2
Completed NCT03194126 - Evaluation of Efficacy of Two Therapeutic Strategies for Cervical Maturation Before Medical Termination N/A
Completed NCT01966874 - Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation Phase 2/Phase 3